WEBVTT

00:00:02.200 --> 00:00:07.961
KPV is only three amino acids long, but its
research story connects hormone

00:00:07.961 --> 00:00:11.312
biology, immune signaling, and the intestinal
lining.

00:00:11.522 --> 00:00:17.167
Its name comes from lysine, proline, and valine:
the final three amino acids of alpha

00:00:17.167 --> 00:00:23.416
melanocyte stimulating hormone, a natural peptide
involved in several biological processes.

00:00:23.611 --> 00:00:28.959
By 1989, Melanie Hiltz and James Lipton at the
University of Texas Southwestern Medical

00:00:28.959 --> 00:00:34.222
Center in Dallas had reported that this small
fragment reduced experimentally induced

00:00:34.222 --> 00:00:35.544
swelling in mice.

00:00:35.732 --> 00:00:39.836
That gives KPV more than thirty-five years of
published research history.

00:00:39.977 --> 00:00:41.818
The gut became an important focus.

00:00:42.020 --> 00:00:47.452
In a 2008 study, Guillaume Dalmasso, Didier Merlin,
and colleagues at Emory University

00:00:47.640 --> 00:00:51.101
investigated a peptide transporter called PepT1.

00:00:51.287 --> 00:00:55.892
Think of this transporter as a doorway into certain
intestinal and immune cells.

00:00:56.077 --> 00:01:01.347
In laboratory experiments, it carried KPV inside,
where researchers observed reduced

00:01:01.347 --> 00:01:06.371
activity in inflammatory signaling pathways,
including nuclear factor kappa B.

00:01:06.453 --> 00:01:11.446
The same research also found reduced inflammation
in two mouse models of colitis.

00:01:11.643 --> 00:01:16.613
A separate German team reported earlier recovery,
improved weight regain, and less

00:01:16.613 --> 00:01:19.803
inflammatory damage in additional mouse studies
published that year.

00:01:20.082 --> 00:01:24.513
These findings explain the interest: could a tiny
fragment of a natural hormone help

00:01:24.513 --> 00:01:28.436
regulate excessive inflammation, particularly in
the digestive tract?

00:01:28.585 --> 00:01:30.322
The results are preclinical.

00:01:30.439 --> 00:01:35.843
Human cell experiments are not human treatment
trials, and mouse colitis is not proof of

00:01:35.843 --> 00:01:39.860
benefit for people with Crohn's disease or
ulcerative colitis.

00:01:40.054 --> 00:01:43.068
KPV is not an FDA-approved treatment.

00:01:43.226 --> 00:01:49.461
Effective human formulations, clinical benefits,
and long-term safety still require investigation.

00:01:49.618 --> 00:01:54.712
Its scientific appeal is clear: three amino acids,
a cellular doorway, and a continuing

00:01:54.712 --> 00:01:57.164
search for more targeted control of inflammation.

00:01:57.406 --> 00:01:58.773
World Peptide Foundation.

00:01:58.966 --> 00:02:00.050
Peptides in 2.

00:02:00.177 --> 00:02:01.626
Every experience matters.